A clinical diagnostic assay for simultaneous detection of SARS-CoV-2 and influenza pathogens. This multiplex testing product incorporates Applied Biocode's Barcoded Magnetic Bead (BMB) technology for comprehensive respiratory pathogen identification.
Manufactured by
United States
Applied BioCode is a leading IVD manufacturer driving advances in multiplex molecular diagnostics for clinical and reference laboratories. Its proprietary Barcoded Magnetic Beads (BMB) technology combines digital barcoding with molecular chemistry to deliver high-throughput, highly accurate detection of multiplex panel targets on a single platform. Applied BioCode delivers flexible, high-throughput solutions on the BioCode MDx-3000 system, featuring FDA-cleared 17-plex respiratory and gastrointestinal panels, SARS-CoV-2 Flu plus RSV combination assays, and RUO panels targeting fungal pathogens and sexually transmitted infections with antimicrobial resistance markers. These solutions help laboratories streamline workflows, expand testing menus, and maximize efficiency.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
KogeneBiotech Co., Ltd.
South Korea · 2 relevant products
SeeGene Middle East FZE
South Korea · 2 relevant products
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 4 relevant products
APPOLON BIOTECK SAS
France · 1 relevant product
Deaou Gene Technology Co.,Ltd
China · 2 relevant products
Coyote Bioscience Co.,Ltd
China · 6 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 3 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 6 relevant products
Biopanda Reagents
United Kingdom · 2 relevant products
HK UNI-MEDICA TECHNOLOGY CO.,LIMITED
China · 1 relevant product
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 114 closest product alternatives
KogeneBiotech Co., Ltd. · South Korea
Multiplex real-time PCR assay enabling simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B from a single sample. This molecular diagnostic test provides efficient multi-pathogen screening in clinical settings.
SeeGene Middle East FZE · South Korea
A multiplex diagnostic assay for the simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syncytial Virus. This assay is part of the Allplex™ product line for comprehensive respiratory infection testing.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A multiplex real-time PCR assay for the VitaPCR™ platform that simultaneously detects Influenza and SARS-CoV-2 from patient samples.
APPOLON BIOTECK SAS · France
Multiplex RT-PCR kit for detection of major respiratory viral infections including SARS-CoV-2, influenza, and respiratory syncytial virus. This test enables simultaneous identification of multiple clinically significant respiratory viruses.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A rapid and accurate diagnostic test for simultaneous detection of influenza and COVID-19 at the point of care. Enables differentiation between respiratory pathogens in 20 minutes.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for influenza virus detection with high sensitivity and specificity. Designed for rapid identification of influenza infections in clinical settings.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
Rapid molecular diagnostic assay for simultaneous detection of SARS-CoV-2, influenza, and RSV. Delivers real-time PCR results in 20 minutes from sample collection, enabling point-of-care testing and immediate clinical decision-making. Designed for deployment in clinical settings to reduce turnaround time and diagnostic costs.
SeeGene Middle East FZE · South Korea
A diagnostic assay for the detection of SARS-CoV-2, the virus responsible for COVID-19. This assay is part of the Allplex™ product line for respiratory infection testing.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for SARS-CoV-2 detection with high sensitivity and specificity. Delivers reliable results for COVID-19 diagnosis in clinical and point-of-care settings.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A rapid and accurate Point-of-Care diagnostic test for influenza and RSV detection. It enables multiplex respiratory viral testing at the point-of-care. Available variants: VitaPCR™ Flu/RSV Assay.
Coyote Bioscience Co.,Ltd · China
A diagnostic test kit for the simultaneous detection of SARS-CoV-2 and influenza A and B virus nucleic acids using fluorescence PCR methodology. The kit enables multiplex detection of COVID-19 and influenza in a single assay.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
102 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products